Member Info for wozzer70

Funny how the critics have no answers, just complaints with insults.

Guess they’ll learn when the results start rolling in.

(Use the filter if my posts bother you)

Why "All Eyes on the SEC" Matters for TEK

The tension for Tekcapital shareholders isn’t just about the IPO happening - it’s about when it happens in relation to the February 17 staleness date.

The Catalyst: The Impact on Tekcapital (TEK)

SEC "Effectiveness" (Pre-Feb 17)

The Snap: Guident goes public on Q3 2025 numbers. Tekcapital’s 70% stake in Guident is instantly crystallised at a public market valuation, likely triggering a sharp rerate toward the 26p NAV. A market correction should follow, bringing Tek’s true value to the forefront.

SEC Delay (Post-Feb 17)

The Slump: Without SEC effectiveness before Feb 17, Guident would likely need a full FY2025 audit. This would add months of delay as "dead time" keeps the spring coiled, frustrating short-term traders and pausing momentum for Tek’s valuation.

Funding Bill Vote (Feb 3)

The Green Light: If the House votes “Yes” tomorrow, the SEC returns to full strength, giving them about 10 days to flick the switch and allow the IPO to go live before the financials go stale.

Bottom Line:

The paperwork is done (6 amendments deep), the price is set ($4–$5), and the commercial case is live (Boca Raton shuttles). The only thing left is for the SEC to return to the office and grant the final "Acceleration Request".

If the government reopens tomorrow as predicted, the February 14–17 window becomes the most anticipated week in TEK’s recent history.

The timeline is tight but entirely viable. If the House votes to reopen the government by Tuesday/Wednesday, it leaves a clear path for Guident to "snap the spring" 🧨 before the February 17 regulatory deadline.

Your "key clue" regarding the February 17 staleness date is exactly what institutional desks are watching.

The Race: Once the government reopens (expected tomorrow or Wednesday), the SEC will have a narrow 10-to-14-day window to grant Guident effectiveness before their Q3 2025 financials expire.

The Risk: Missing this would force Guident into a costly 2025 year-end audit, likely delaying the IPO until April or May 2026.

All Eyes On The (SEC) The Gatekeeper.

Guident is highly incentivised to go effective before their Q3 2025 financials expire on February 17. This isn’t just about being “ready” - it’s a legal race against a massive re-audit delay, which would add months of unnecessary cost and red tape. The fuse is burning short; the SEC just needs to flick the switch once the government funding bill passes this week. The "coiled spring" 🧨 has a clear expiration date for its current filing.

Active Shutdown: As of today, February 2, the SEC is operating with a "very limited number of staff" due to a lapse in federal appropriations that began at midnight on January 31.

Resolution Outlook: House Speaker Mike Johnson has expressed confidence that the funding impasse—primarily over Department of Homeland Security reforms—could be resolved as early as Tuesday, February 3 or Wednesday, February 4.

EDGAR System: The EDGAR system remains operational for filings, but the "Notice of Effectiveness" (which allows the IPO to proceed) requires active SEC staff review, which is restricted during the shutdown.

https://www.sec.gov/#:~:text=SEC%20Operational%20Status,certain%20Commission%20systems%2C%20including%20EDGAR.

Backlog Priority: Coming out of the previous major shutdown (late 2025), the SEC explicitly prioritised the 900+ backlogged registration statements over routine financial reviews. If this February shutdown is as short as predicted, Guident should remain at the front of the queue.

February 2026 Deadlines: For companies with a December 31 fiscal year-end, February 17, 2026, is a key "staleness date" for Q3 2025 financials. Guident likely aims to go effective before this date to avoid needing another major financial audit amendment.

https://www.kirkland.com/publications/kirkland-alert/2026/01/2026-sec-filing-deadlines-and-staleness-dates-for-public-companies#:~:text=Kirkland%20Alert-,2026%20SEC%20Filing%20Deadlines%20and%20Staleness%20Dates%20for%20Public%20Companies,Q2%202026%20Financials

The "fuse is lit," but the "SEC matches" are temporarily in a drawer until the funding bill passes this week. If the government reopens by February 4 as anticipated, a mid-to-late February IPO remains a highly viable target.

The "Power of Four" Portfolio Disruptors

Guident (The Catalyst): The IPO is imminent. $4–$5 is the floor, not the ceiling. Tek’s 70% stake is massively undervalued in comparison to its market cap. The market’s about to wake up.

GenIP (The Engine): AI-driven tech-transfer that’s building the next-gen portfolio for pennies on the dollar. Nobody’s talking about this game-changer.

MicroSalt (The Multi-Industry Play): Beyond snacks, this sub-20 micron tech is a pharma and cosmetic disruptor waiting for B2B contracts. Think big potential.

Lucyd (The Revenue): Record sales growth proves it’s scaling and commercialised. Real revenue, real momentum.

Bottom line: Trading at a ~60% discount to a 26p NAV. The Guident IPO is the liquidity event that will unlock value. Once cash starts flowing back into Tek from loans and exits, that coiled spring snaps.

DYOR. The numbers don’t lie. ⏳

When Will the Spring Uncoil?

The “spring” will likely uncoil once the market sees tangible progress, particularly from:

The successful IPO of Guident.

The continued growth and scalability of Tek’s key subsidiaries.

The monetisation of those companies (i.e., partial exits, dividends, and realisations of value).

Once Guident’s IPO happens, expect the spring to snap, and Tek’s valuation to adjust closer to its true NAV. The market realises Tek is undervalued, and the spring releases - driving positive revaluation.

Why This Matters:

The current valuation discount creates an opportunity for upside, as the market hasn’t fully priced in the future growth and value from Tek’s key assets. As Tek moves forward through key milestones, the coiled spring effect will kick into gear, and the value gap will close, leading to:

Rerating of Tek’s NAV closer to its true value.

Increased investor confidence as key events unfold.

Potential material upside once the market begins to price in the full value of Tek's assets.

In summary, Tekcapital's current undervaluation represents the tension in the coiled spring, which will unwind as the Guident IPO and other monetisation events unfold. The market is holding back until it sees clear signals of progress, but once those signals are clear, expect a revaluation that reflects Tek's true value.

Funny how the loudest critics are always the ones doing the least homework. You’d think they’d be able to do a bit of research with all the time spent complaining. 📉🤔

As of February 2026, Tekcapital still trades at a significant discount to its Net Asset Value (NAV), which was reported at approximately 26p in late 2025. The long-term disruption lies in the compounding of these four distinct pillars:

1, Food Tech (MicroSalt)

2, Wearable AI (Innovative Eyewear)

3, Autonomous Mobility (Guident)

4, Generative AI Services (GenIP)

By holding 2026's most disruptive technologies under one roof, Tekcapital isn't just a single stock; it's a diversified technology, trading at an "undiscovered" valuation. As these subsidiaries scale towards individual multi million valuations, the parent company's structural value becomes impossible for the LSE to ignore.

The Stage Is Set:

All eyes are on the incoming Guident IPO; The spring is coiled, the fuse is lit. 🧨

I’ve put together a structured, long-form framework outlining what would need to happen for Tekcapital to sustain a £1.00 valuation over the long term.

This is not a price prediction or investment advice, but a conditional roadmap covering portfolio validation, monetisation, capital return, and institutional re-rating.

Link below for anyone interested in a deeper, evidence-based view

https://docs.google.com/document/d/1SQKCF-fz-Aa2IVc2_dtrAvKnGeTsQ_dtkCr8RsxSzdI/edit?usp=drivesdk

In terms of timing, the step Guident has just taken (an exhibits‑only S‑1/A with no further prospectus edits) typically sits in the later part of the SEC review cycle. In a normal environment that often means weeks rather than many months from effectiveness – but it remains entirely in the hands of the SEC and the underwriters.

That’s why I’m deliberately avoiding specific dates. The process looks late‑stage, but the exact timing depends on SEC workload and market conditions, not bulletin‑board commentary.

I’ve outlined what this amendment is, what it signals procedurally, and what the logical next steps are. From here, it’s down to the SEC, the underwriters and the tape – so I’ll leave it there until there’s a material new filing or RNS to discuss.

For those following TEK, the likely triggers for meaningful moves are straightforward:

1️⃣ SEC Effectiveness & IPO Launch – Confirms Guident is officially green‑lighted. Even before trading begins, anticipation often drives positioning in TEK.

2️⃣ IPO Pricing & First Day of Trading – Where supply meets demand. Early trading sets the tone and creates the first real NAV read‑through.

3️⃣ TEK RNS Linking Guident to Cash / NAV / Dividends – Once TEK shows how monetisation flows back to the balance sheet or shareholders, the longer‑term rerate can start to be reflected in the share price.

The pattern is clear: Anticipation moves, execution confirms, Cash crystallisation ultimately rewards shareholders.

Once an S‑1 stops changing and starts being finalised, it’s no longer a question of if the bell rings – only when. When the lawyers are focused on exhibits and signatures, the prospectus has already done its job. At this stage, an S‑1 isn’t a draft – it’s a launchpad.

What logically comes next (process, not hope)

Given that:

There are no material prospectus changes in this amendment

Exhibits now look substantially final

Incentive plans, employment, consulting agreements and warrants are all drafted to kick in on consummation

A fresh auditor consent has been filed

The highest‑probability next steps are:

1, SEC effectiveness declared (often without much fanfare)

2, Pricing / allocation window opens with the underwriters

3, Nasdaq ticker and first trade date announced very close to the actual debut

And worth remembering: the “effective” notice itself often feels anticlimactic when it lands – because most of the real work has already been done by that point.

Worth flagging the significance of last night’s Guident filing.

Guident has just filed Amendment No. 6 to its S‑1, dated 28 January 2026 – and it’s described as an “exhibits‑only” amendment. In plain English, they are no longer rewriting the prospectus; they are locking down all the legal plumbing needed to go effective and trade.

​

Key points from the filing:

The body of the S‑1 is unchanged – this amendment only updates the facing page, an explanatory note, the exhibit list, signatures and the exhibits themselves.

​

The exhibit list now includes final forms of the underwriting agreement, representative’s warrant, amended charter and by‑laws to be in force at closing, updated note/convertible note amendments, equity incentive plans, key employment and consulting agreements, and a fresh auditor consent from Cherry Bekaert LLP.

​

This is exactly the type of housekeeping you see when a deal moves from “being shaped” to “being prepared to trade”: the lawyers are finishing the documents the SEC and underwriters need on file before declaring the registration effective and taking orders.

We still don’t have the magic word “effective” or a Nasdaq date in this amendment, so the final green light is with the SEC and the brokers. But the direction of travel is clear: Guident isn’t going back to the drawing board – it’s tidying up the last pieces needed to get this IPO over the line.

AMENDMENT NO. 6

TO

FORM S-1

https://www.sec.gov/Archives/edgar/data/2066926/000182912626000688/guidentcorp_s1a6.htm

Markets don’t punish people for being wrong - they punish people for refusing to update their thinking.

TEK is evolving, and those who don’t evolve with it will simply be left behind.

For anyone newer to TEK, here’s a straightforward way to view the investment without getting lost in daily noise:

1️⃣ Stop watching the share price

TEK isn’t a momentum trade at this stage. Price follows events, not the other way around.

2️⃣ Understand the portfolio roles

Each holding does something different:

Guident – near-term catalyst + monetisation engine

MicroSalt – revenue growth and compounding value

Lucyd / GenIP – optional upside and bonus monetisation

TEK – the allocator and distributor of value

3️⃣ Follow filings, not forum sentiment

RNSs, reports, and filings show intent and execution. Sentiment follows later.

4️⃣ Think in cash events, not paper NAV

NAV matters when it turns into cash:

Partial sell-downs

Dividends / special dividends

Repayments and exits

This is how discounts close.

5️⃣ Guident IPO = inflection point

A clean listing makes the value visible and opens the door to staged monetisation. That’s when TEK’s model becomes clear to the wider market.

6️⃣ MicroSalt is the compounding leg

Execution, scale, and selective monetisation over time can quietly do a lot of heavy lifting for NAV.

7️⃣ Reframe expectations

This isn’t about a single spike. It’s about unlocking value step by step, one monetisation at a time.

Bottom line:

If you understand portfolio roles + monetisation pathways, you understand TEK.

Everything else is noise.

For anyone following TEK, it’s worth looking past the daily noise and thinking structurally about where value comes from:

1️⃣ Guident IPO – Clean listing = NAV reset, market sees the stake clearly. Early trading & institutional uptake will set the tone.

2️⃣ Monetisation – Partial exits, repayments, and dividends from Guident, MicroSalt, Lucyd, and GenIP are the real value unlockers. These are cash events that compound TEK’s NAV.

3️⃣ Portfolio execution – MicroSalt scaling, Lucyd/GenIP traction, and any licensing or partnerships layer additional upside. Each success strengthens TEK’s rerate case.

4️⃣ Long-term view – TEK is now a NAV + cashflow story. Focus on milestones, not daily swings.

Those aligned with monetisation and portfolio execution will see the upside as it unfolds.

Bottom line: TEK is entering a phase where numbers, monetisation, and execution matter more than sentiment. Keep your eyes on the events that really move value.

These are my opinions on how I see the TEK landscape. Always do your own due diligence ✍️ before making any investment decisions.

Investors who grasp the dynamics within TEK’s portfolio see the bigger picture:

Each business has a role to play, some generate recurring cash, some optionality, some high upside.

Monetisation events (IP exits, partial sell-downs, dividends) are what turn paper NAV into real value for shareholders.

Simply watching the share price misses the story; following the numbers and filings shows where real gains will come from.

Think in terms of portfolio performance + monetisation = NAV expansion. That’s the framework long-term holders use to identify TEK’s rerate potential.

The story isn’t about a spike, it’s about unlocking value step by step, one monetisation at a time.

A clean Guident IPO will help close TEK’s NAV gap. After that, future monetisation events are the key to unlocking real value for the company and shareholders

Thanks Pedro, much appreciated.

I try to keep my posts anchored to filings and the numbers, because that’s what reveals the full story. Once one follows the RNSs/Filings, the rest just becomes noise, sometimes filtered if that doesn't fit the narrative here.

The story here is now in my opinion is just starting to wake up, a rise from the ashes, like a phoenix scenario.

Those that understand all the workings here, again in my opinion will be the ones most rewarded for the years to come.

Appreciate you 🙏